Display options
Cite
Steverding D. The development of drugs for treatment of sleeping sickness: a historical review. Parasit Vectors. 2010;3(1):15doi: 10.1186/1756-3305-3-15.
Steverding, D. (2010). The development of drugs for treatment of sleeping sickness: a historical review. Parasites & vectors, 3(1), 15. https://doi.org/10.1186/1756-3305-3-15
Steverding, Dietmar. "The development of drugs for treatment of sleeping sickness: a historical review." Parasites & vectors vol. 3,1 (2010): 15. doi: https://doi.org/10.1186/1756-3305-3-15
Steverding D. The development of drugs for treatment of sleeping sickness: a historical review. Parasit Vectors. 2010 Mar 10;3(1):15. doi: 10.1186/1756-3305-3-15. PMID: 20219092; PMCID: PMC2848007.
Copy Download .nbib Format: NLM
Share it on

Parasit Vectors. 2010 Mar 10;3(1):15. doi: 10.1186/1756-3305-3-15.

The development of drugs for treatment of sleeping sickness: a historical review.

Parasites & vectors

Dietmar Steverding

Affiliations

  1. BioMedical Research Centre, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ, UK. [email protected].

PMID: 20219092 PMCID: PMC2848007 DOI: 10.1186/1756-3305-3-15

Abstract

Only four drugs are available for the chemotherapy of human African trypanosomiasis or sleeping sickness; Suramin, pentamidine, melarsoprol and eflornithine. The history of the development of these drugs is well known and documented. suramin, pentamidine and melarsoprol were developed in the first half of the last century by the then recently established methods of medicinal chemistry. Eflornithine, originally developed in the 1970s as an anti-cancer drug, became a treatment of sleeping sickness largely by accident. This review summarises the developmental processes which led to these chemotherapies from the discovery of the first bioactive lead compounds to the identification of the final drugs.

References

  1. Clin Cancer Res. 1999 May;5(5):945-51 - PubMed
  2. Ann Trop Med Parasitol. 1959 Apr;53(1):1-9 - PubMed
  3. Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):254-6 - PubMed
  4. Trends Parasitol. 2003 Nov;19(11):488-94 - PubMed
  5. Expert Opin Investig Drugs. 2005 Aug;14(8):957-72 - PubMed
  6. PLoS Clin Trials. 2006 Dec 08;1(8):e39 - PubMed
  7. Clin Infect Dis. 2007 Dec 1;45(11):1435-42 - PubMed
  8. PLoS Negl Trop Dis. 2007 Nov 07;1(2):e64 - PubMed
  9. Ann Trop Med Parasitol. 1948 Dec;42(3-4):357-63 - PubMed
  10. Am J Trop Med Hyg. 1949 Mar;29(2):173-80 - PubMed
  11. Parasit Vectors. 2008 Feb 12;1(1):3 - PubMed
  12. Pharmacology. 2008;82(3):171-9 - PubMed
  13. Lancet. 2009 Jul 4;374(9683):56-64 - PubMed
  14. Antimicrob Agents Chemother. 2009 Oct;53(10):4185-92 - PubMed
  15. JAMA. 1991 Mar 13;265(10):1229 - PubMed
  16. Lancet. 1947 Nov 8;2(6480):686-8 - PubMed
  17. Br Med J. 1924 Mar 8;1(3297):413-4 - PubMed
  18. Med Trop (Mars). 1989 Apr-Jun;49(2):149-54 - PubMed
  19. Trans R Soc Trop Med Hyg. 1989 Jul-Aug;83(4):514-7 - PubMed
  20. Lancet. 1987 Dec 19;2(8573):1431-3 - PubMed
  21. Ind Med Gaz. 1942 Feb;77(2):71-74 - PubMed
  22. Am J Trop Med Hyg. 1987 Nov;37(3):525-33 - PubMed
  23. J Med Chem. 1977 Apr;20(4):531-6 - PubMed
  24. Trans R Soc Trop Med Hyg. 1985;79(5):692-8 - PubMed
  25. Annu Rev Biochem. 1984;53:749-90 - PubMed
  26. Science. 1980 Oct 17;210(4467):332-4 - PubMed
  27. Acta Chem Scand B. 1980;34(6):457-8 - PubMed
  28. Biochem Pharmacol. 1981 Jul 15;30(14):1947-51 - PubMed
  29. Exp Parasitol. 1982 Feb;53(1):133-44 - PubMed
  30. Acta Trop. 1993 Sep;54(3-4):153-62 - PubMed
  31. Antimicrob Agents Chemother. 1997 Sep;41(9):1922-5 - PubMed

Publication Types